AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$376M |
| 2 |
Honeywell
HON
|
+$325M |
| 3 |
Progressive
PGR
|
+$288M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$232M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
+$529M |
| 2 |
RTX Corp
RTX
|
+$496M |
| 3 |
CVS Health
CVS
|
+$406M |
| 4 |
US Bancorp
USB
|
+$395M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.51% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Fabrinet
FN
$15.6B
| $1.85M | ﹤0.01% |
45,821
| – | – |
|
1877
iShares MSCI Japan ETF
EWJ
$21.9B
| $1.85M | ﹤0.01% |
37,777
+34,428
| +1,028% | +$1.72M |
|
|
ESV
1878
DELISTED
Ensco Rowan plc
ESV
| $1.84M | ﹤0.01% |
47,388
-1,196
| -2% | -$42.9K |
|
|
BOBE
1879
DELISTED
Bob Evans Farms, Inc.
BOBE
| $1.84M | ﹤0.01% |
34,557
+1,600
| +5% | +$72.1K |
|
|
IMPV
1880
DELISTED
Imperva, Inc.
IMPV
| $1.84M | ﹤0.01% |
47,850
| – | – |
|
|
AMED
1881
DELISTED
Amedisys
AMED
| $1.84M | ﹤0.01% |
43,069
+31
| +0.1% | +$1.32K |
|
|
ALOG
1882
DELISTED
Analogic Corp
ALOG
| $1.83M | ﹤0.01% |
22,099
| – | – |
|
|
UNVR
1883
DELISTED
Univar Solutions Inc.
UNVR
| $1.83M | ﹤0.01% |
64,478
+5,200
| +9% | +$126K |
|
|
NTUS
1884
DELISTED
Natus Medical Inc
NTUS
| $1.83M | ﹤0.01% |
52,566
-30
| -0.1% | -$1.18K |
|
|
RDS.A
1885
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.83M | ﹤0.01% |
33,612
-2,571
| -7% | -$132K |
|
|
EXAC
1886
DELISTED
Exactech Inc
EXAC
| $1.83M | ﹤0.01% |
66,976
-27,010
| -29% | -$714K |
|
1887
First Busey Corp
BUSE
$2.57B
| $1.83M | ﹤0.01% |
59,343
-38,960
| -40% | -$1.01M |
|
1888
Theravance Biopharma
TBPH
$874M
| $1.82M | ﹤0.01% |
57,235
| – | – |
|
1889
Babcock & Wilcox
BW
$1.39B
| $1.82M | ﹤0.01% |
10,964
-9,761
| -47% | -$1.56M |
|
|
TUP
1890
DELISTED
Tupperware Brands Corporation
TUP
| $1.82M | ﹤0.01% |
34,503
-515
| -1% | -$30.2K |
|
|
VSM
1891
DELISTED
Versum Materials, Inc.
VSM
| $1.82M | ﹤0.01% |
+64,712
| New | +$1.61M |
|
1892
Opko Health
OPK
$985M
| $1.81M | ﹤0.01% |
195,021
-1,911
| -1% | -$19.8K |
|
|
MANT
1893
DELISTED
Mantech International Corp
MANT
| $1.81M | ﹤0.01% |
42,907
-109,820
| -72% | -$4.52M |
|
|
WFBI
1894
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $1.81M | ﹤0.01% |
62,495
-8,215
| -12% | -$207K |
|
|
KATE
1895
DELISTED
Kate Spade & Company
KATE
| $1.81M | ﹤0.01% |
97,037
+23,892
| +33% | +$391K |
|
|
TLRD
1896
DELISTED
Tailored Brands, Inc.
TLRD
| $1.81M | ﹤0.01% |
70,795
| – | – |
|
1897
Andersons Inc
ANDE
$2.41B
| $1.8M | ﹤0.01% |
40,320
| – | – |
|
|
ASRT
1898
PUT
DELISTED
Assertio
ASRT
| $1.8M | ﹤0.01% |
+1,667
| New | +$2.12M |
|
|
PETX
1899
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.8M | ﹤0.01% |
250,850
+54,600
| +28% | +$441K |
|
|
CSR
1900
Centerspace
CSR
$921M
| $1.8M | ﹤0.01% |
25,222
+170
| +0.7% | +$10.8K |
|
Similar funds
AllianceBernstein's Q4 2016 Portfolio in Review
As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
- AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
- AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
- AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
- AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
- AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.